0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
13 Ansichten17 Seiten
This document discusses strategies and targets for eliminating maternal and neonatal tetanus, including immunizing pregnant women with tetanus toxoid vaccines. It provides background on tetanus as a disease caused by bacteria found in the environment. Prevention is through immunizing women of childbearing age, especially with two doses during pregnancy to protect newborns. Data is presented on neonatal tetanus death reduction from 1997-2002 and levels of neonatal tetanus protection in various countries and regions based on vaccination coverage of pregnant women.
This document discusses strategies and targets for eliminating maternal and neonatal tetanus, including immunizing pregnant women with tetanus toxoid vaccines. It provides background on tetanus as a disease caused by bacteria found in the environment. Prevention is through immunizing women of childbearing age, especially with two doses during pregnancy to protect newborns. Data is presented on neonatal tetanus death reduction from 1997-2002 and levels of neonatal tetanus protection in various countries and regions based on vaccination coverage of pregnant women.
This document discusses strategies and targets for eliminating maternal and neonatal tetanus, including immunizing pregnant women with tetanus toxoid vaccines. It provides background on tetanus as a disease caused by bacteria found in the environment. Prevention is through immunizing women of childbearing age, especially with two doses during pregnancy to protect newborns. Data is presented on neonatal tetanus death reduction from 1997-2002 and levels of neonatal tetanus protection in various countries and regions based on vaccination coverage of pregnant women.
International Goals & Targets MDG 5: Reduce by three quarters the maternal mortality ratio
Strategy: Elimination of maternal and neonatal tetanus
Target: Reduce incidence of neonatal tetanus to less than 1 case of neonatal tetanus per 1000 live births in every district
International Goals & Targets By 2005, Reduction in infant and under-five mortality rate by at least 1/3, in pursuit of the goal of reducing it by 2/3 by 2015
Eliminate maternal and neonatal tetanus by 2005 Background Caused by tetanus spores, a bacteria found everywhere in the environment Transmission occurs when there is contact with broken skin such as an infants umbilical cord Poverty, poor hygiene and limited access to health services increase the risk for transmission during childbirth
Background Prevention is possible by:
1. Immunization of pregnant women with at least 2 doses of tetanus toxoid vaccine (TT2+), passing protection to the newborn for up to first two months of life 2. Immunization of women of childbearing age who live in areas of high risk for transmission (delivery of immunizations usually through campaigns) 3. Promotion of clean delivery and cord care practices
Background Deaths of children by cause for vaccine preventable diseases (As of March 2004; source WHO) Cause 2002
Under 5 Over 5 Diphtheria 4,000 1,000 Measles 540,000 71,000 Poliomyelitis .. .. Tetanus (excluding NT) 18,000 15,000 Neonatal Tetanus 180,000 .. Pertussis 294,000 Yellow Fever 15,000 15,000 Haemophilus Influenzae B 413,000 Total 1,464,000 102,000 Note: The boundaries and the names shown and the designations used on these maps do not imply official endorsement or acceptance by the United Nations. MNT not eliminated Countries with TT campigns MNT eliminated * includes Timor-Leste 1997 2000 2002 248,000 200,000 180,000 Neonatal Tetanus death reduction Situation of Maternal and Neonatal Tetanus (Remains a problem in 48 countries) Indicator Neonatal tetanus protection (protection at birth against tetanus) Numerator Number of mothers of live births in the previous year with at least two doses of TT within appropriate interval prior to infants birth Denominator Total number of women surveyed aged 15- 49 years with a birth in the year preceding the survey Methodological issues -Data collected for all births during the 2 years before the survey indicator includes only those during the last one year -Complex algorithm for the estimation of the numerator Methodological issues o two TT doses during the pregnancy (TT3>=2) o one TT dose during the pregnancy and at least one TT dose prior to the pregnancy (TT3=1 AND TT6>=1) o at least two TT doses prior to the pregnancy of which the last dose was less than 3 years before the birth o with 3 doses within the 5 years before the pregnancy o with 4 doses with the last dose less than 10 years before the pregnancy o with 5 doses or more ever (TT6>=5).
Country data CEE/CIS Neonatal tetanus protection (%), 2004 Turkey 41% Country data Eastern and Southern Africa Neonatal tetanus protection (%),2004 62 45 45 46 53 55 60 60 61 62 67 70 70 70 75 76 83 90 0 10 20 30 40 50 60 70 80 90 100 Eastern and Southern Africa Burundi Ethiopia Comoros Uganda Madagascar Mozambique Somalia South Africa Eritrea Namibia Kenya Malawi Zimbabwe Angola Rwanda Zambia Tanzania Country data West and Central Africa Neonatal tetanus protection (%), 2004 57 33 35 40 40 42 43 45 50 51 56 58 60 61 65 65 69 70 75 76 77 85 0 10 20 30 40 50 60 70 80 90 100 West and Central Af rica Mauritania Liberia Equitorial Guinea Chad Central Af rican Niger Gabon Mali Nigeria Guinea-Bissau Congo Dem. Rep. Cameroon Togo Burkina Faso Congo Benin Ghana Cte dIvoire Sierra Leone Guinea Senegal Country data MENA Neonatal tetanus protection (%), 2004 21 37 70 71 0 20 40 60 80 100 Yemen Sudan Iraq Egypt Country data LAC Neonatal tetanus protection (%), 2004 Haiti 52% Country data South Asia Neonatal tetanus protection (%), 2004 70 35 42 45 45 80 0 10 20 30 40 50 60 70 80 90 100 South Asia Afghanistan Nepal Bangladesh Pakistan India Country data East Asia and the Pacific Neonatal tetanus protection (%), 2004 10 30 51 54 70 85 85 0 10 20 30 40 50 60 70 80 90 100 Papua New Guinea Lao PDR Cambodia Indonesia Philippines Myanmar Vietnam